Compare Tango Therapeutics Inc. (TNGX) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Tractor Supply Co — how do they compare? Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B), while Tractor Supply Co trades at $32.8 (market cap $17.56B). The key difference: Tractor Supply Co is far larger — about 4.7× Tango Therapeutics Inc.'s market cap, and Tractor Supply Co pays a 2.85% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Tractor Supply Co for 89 Days on average.
| TNGX | TSCO | |
|---|---|---|
Market Cap | $3.75B | $17.56B |
Volume | 9,619,106 | 9,523,235 |
Sector | Health | Consumer Cyclical |
52-Week High | $32.90 | $56.37 |
52-Week Low | $7.50 | $29.14 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $2.77B | $23.87B |
Dividend Yield | — | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Tractor Supply (TSCO) trades at $32.74, down 2.12% today amid recent earnings misses. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Fundamentally, the company maintains solid profitability with 36.46% gross margins and 39.51% ROE, though revenue growth has slowed to 4.2% annually. Recent news highlights dividend sustainability concerns after two consecutive quarterly misses and a 17-year dividend growth streak.
Outlook remains cautious with analyst consensus at $36.76 target (12% upside) but recent institutional selling and earnings disappointments create near-term headwinds. Key risks include competitive pressures, rural consumer spending volatility, and margin compression from 7.66% to 6.42% over four years. The dividend yield of 0.73% provides income support while growth initiatives target pet care and logistics optimization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
